Evercore ISI Group Maintains In-Line on Moderna, Raises Price Target to $35

Moderna -1.55%

Moderna

MRNA

52.56

-1.55%

Evercore ISI Group analyst Cory Kasimov maintains Moderna (NASDAQ: MRNA) with a In-Line and raises the price target from $28 to $35.
Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via